|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
It remains unclear whether B cell lymphomas with MYD88 L265P mutation respond differently toward CD8<sup>+</sup> T cell-mediated cytotoxicity.
|
30253331 |
2018 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.
|
27837631 |
2017 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
9/20 other B-cell lymphomas with identical light chain restriction on B-cells and plasma cells were genotypically identical by PCR and MYD88 L265P was detected in both cell fractions in 7/9 whereas in 11/20 specimens with different clonal origin, MYD88 L265P was absent (5/11), or only found in B-lymphocytes (4/11), or plasma cells (2/11).
|
27890075 |
2016 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Thirty-three low-grade B-cell lymphomas with plasmacytic differentiation (23 MYD88(L265P) and 10 MYD88(WT)) involving various samples types (fresh and formalin-fixed tissues) formed the study group.
|
27268124 |
2016 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
In conclusion the detection of MYD88 L265P mutation in FFPE samples is reliable and useful for subtyping small B-cell lymphomas in BM biopsies.
|
25819228 |
2015 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
To assess the diagnostic utility of MYD88 L265P mutation in diagnosing low-grade B-cell lymphomas.
|
26230596 |
2015 |
|
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Although not entirely specific, MYD88 L265P is a useful adjunct for bone marrow diagnosis in separating LPL from other small B-cell lymphomas and plasma cell myeloma.
|
23955458 |
2013 |
|
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
BRAF-V600E is the key driver mutation in HCL and distinguishes it from other B-cell lymphomas, including HCL-like leukemias/lymphomas (HCL-variant and splenic marginal zone lymphoma).
|
25480661 |
2015 |
|
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
|
26071465 |
2015 |
|
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
|
26071465 |
2015 |
|
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
BRAF-V600E is the key driver mutation in HCL and distinguishes it from other B-cell lymphomas, including HCL-like leukemias/lymphomas (HCL-variant and splenic marginal zone lymphoma).
|
25480661 |
2015 |
|
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Here, we confirm the specificity of BRAF V600E for HCL among low and intermediate grade B-NHL and describe a real-time polymerase chain reaction method for detecting this mutation in cases with low tumour burden.
|
22246856 |
2012 |
|
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Here, we confirm the specificity of BRAF V600E for HCL among low and intermediate grade B-NHL and describe a real-time polymerase chain reaction method for detecting this mutation in cases with low tumour burden.
|
22246856 |
2012 |
|
rs17757541
|
|
|
0.020 |
GeneticVariation |
BEFREE |
B-cell lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of coronary artery disease in a Chinese population.
|
26823859 |
2015 |
|
rs17757541
|
|
|
0.020 |
GeneticVariation |
BEFREE |
B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population.
|
23991993 |
2013 |
|
rs1800629
|
|
|
0.020 |
GeneticVariation |
BEFREE |
TNF rs1800629, which was genotyped in only two of our studies, was also associated with B cell lymphoma (per-allele OR = 0.77, 95 % CI 0.64-0.91; p trend = 0.003), specifically DLBCL (per-allele OR = 0.69, 95 % CI 0.55-0.86; p trend = 0.001).
|
23640160 |
2013 |
|
rs1800629
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Statistically significant interactions with blood transfusion were observed for IL10RA (rs9610) (P(forinteraction) = 0.003) and TNF (rs1800629) (P(forinteraction) = 0.012) for NHL overall and IL10RA (rs9610) (P(forinteraction) = 0.001) and TNF (rs1800629) (P(forinteraction) = 0.019) for B-cell lymphoma.
|
22649007 |
2012 |
|
rs121912438
|
|
|
0.010 |
GeneticVariation |
BEFREE |
RESULTS Ovariectomy advanced the onset of disease, down-regulated aromatase and estrogen receptor alpha (ER-a) expression, and inhibited expression of the anti-inflammatory factors arginase-1 and the anti-apoptotic factor B-cell lymphoma-2 (Bcl-2) in the lumbar spinal cord of hSOD1-G93A transgenic mice.
|
29394243 |
2018 |
|
rs2230926
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A coding <i>TNFAIP3</i> variant, namely rs2230926, has been previously linked to B cell non-Hodgkin's lymphoma (NHL) development in patients with Sjogren's syndrome (SS) of French and UK origin.
|
30662920 |
2018 |
|
rs11886868
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated the association between B-cell lymphoma/leukaemia 11A (BCL11A) rs11886868 and rs4671393 polymorphism, plasma BCL11A concentration, and the hazard of developing laryngeal squamous cell carcinoma (LSCC).
|
28225775 |
2017 |
|
rs1472503583
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.
|
27837631 |
2017 |
|
rs4671393
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated the association between B-cell lymphoma/leukaemia 11A (BCL11A) rs11886868 and rs4671393 polymorphism, plasma BCL11A concentration, and the hazard of developing laryngeal squamous cell carcinoma (LSCC).
|
28225775 |
2017 |
|
rs1057520009
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In this retrospective study, we analyzed the recurrent hotspot mutation of the exportin 1 (XPO1, p.E571K) gene, previously identified in primary mediastinal B-cell lymphoma, in biopsies and plasma circulating cell-free DNA from patients with classical Hodgkin lymphoma using a highly sensitive digital PCR technique.
|
27479820 |
2016 |
|
rs539846
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SNP rs539846 C>A, the most highly associated variant (p = 1.42 × 10(-13), odds ratio = 1.35), localizes to a super-enhancer defined by extensive histone H3 lysine 27 acetylation in intron 3 of B cell lymphoma 2 (BCL2)-modifying factor (BMF).
|
27524613 |
2016 |
|
rs17655
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ERCC5 Asp1104His polymorphism showed a protective effect against the B-NHL in individuals carrying this mutant allele (p = 0.009), and differences were more prominent in males (p = 0.001).
|
25400036 |
2015 |